0.00
price down icon100.00%   -0.7206
 
loading
Cyclo Therapeutics Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
See More
Previous Close:
$0.7206
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$25.21M
Revenue:
$1.13M
Net Income/Loss:
$-20.74M
P/E Ratio:
0.00
EPS:
-0.88
Net Cash Flow:
$-18.37M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$0.00
$0.00
52-Week Range:
Value
$0.00
$1.6199

Cyclo Therapeutics Inc Stock (CYTH) Company Profile

Name
Name
Cyclo Therapeutics Inc
Name
Phone
386-418-8060
Name
Address
6714 NW 16TH STREET, SUITE B, GAINESVILLE
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
CYTH's Discussions on Twitter

Compare CYTH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CYTH
Cyclo Therapeutics Inc
0.00 25.21M 1.13M -20.74M -18.37M -0.88
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
157.44 68.46B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.32 47.30B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.70 45.89B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.19 17.90B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
294.60 13.14B 2.76B 1.11B 898.10M 22.77

Cyclo Therapeutics Inc Stock (CYTH) Latest News

pulisher
Apr 29, 2025

Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times

Apr 29, 2025
pulisher
Apr 29, 2025

Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan

Apr 29, 2025
pulisher
Apr 26, 2025

Cyclo Therapeutics (NASDAQ:CYTH) and Genfit (NASDAQ:GNFT) Financial Comparison - Defense World

Apr 26, 2025
pulisher
Apr 24, 2025

Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phase 3 Trial for Niemann-Pick Disease Treatment - Nasdaq

Apr 24, 2025
pulisher
Apr 24, 2025

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces - Bluefield Daily Telegraph

Apr 24, 2025
pulisher
Apr 24, 2025

Rafael Holdings Pivots to Breakthrough Rare Disease Drug Development as Leadership Changes - Stock Titan

Apr 24, 2025
pulisher
Apr 03, 2025

Contrasting BioNTech (NASDAQ:BNTX) and Cyclo Therapeutics (NASDAQ:CYTH) - Defense World

Apr 03, 2025
pulisher
Mar 26, 2025

Rafael Holdings finalizes merger with Cyclo Therapeutics By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Rafael Closes Merger With Cyclo Therapeutics - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Rafael Holdings and Cyclo Therapeutics Merge - citybiz

Mar 26, 2025
pulisher
Mar 26, 2025

Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Cyclo Therapeutics Merges with Rafael Holdings - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Rafael Holdings Completes Merger with Cyclo Therapeutics - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Rafael Holdings finalizes merger with Cyclo Therapeutics - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Major Pharma Merger: Rafael Holdings Gains Phase 3 Rare Disease Asset in Strategic Deal - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger By Investing.com - Investing.com Canada

Mar 25, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger - Investing.com

Mar 25, 2025
pulisher
Mar 24, 2025

Cyclo Therapeutics shareholders approve merger with Rafael Holdings By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Cyclo Therapeutics shareholders approve merger with Rafael Holdings - Investing.com

Mar 24, 2025
pulisher
Mar 23, 2025

WILLIAM SHANAHAN Obituary (2025)New York, NYNew York Times - Legacy.com

Mar 23, 2025
pulisher
Mar 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

March Madness: Flutter Stock Is a Solid Bet on Sustained Growth - The Globe and Mail

Mar 20, 2025
pulisher
Mar 20, 2025

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office - Business Wire

Mar 20, 2025
pulisher
Mar 18, 2025

Q4 Earnings Highlights: Apogee (NASDAQ:APOG) Vs The Rest Of The Commercial Building Products Stocks - The Globe and Mail

Mar 18, 2025
pulisher
Mar 17, 2025

Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) - Business Wire

Mar 17, 2025
pulisher
Mar 15, 2025

CYCLO THERAPEUTICS Earnings Preview: Recent $CYTH Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 14, 2025

Rafael Holdings Inc Reports Q2 2025 Earnings: EPS at -$0.19, Str - GuruFocus.com

Mar 14, 2025
pulisher
Mar 14, 2025

Rafael Holdings, Inc. SEC 10-Q Report - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Rafael Holdings, Inc. Reports Financial Results and Anticipates Closure of Merger with Cyclo Therapeutics in Q3 - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 10, 2025

Cyclo Therapeutics (CYTH) to Release Quarterly Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Cyclo Therapeutics secures $2.5 million in funding By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 07, 2025

Is Cyclo Therapeutics, Inc. (CYTH) the Best Micro Cap Stock to Buy Now? - Insider Monkey

Mar 07, 2025
pulisher
Mar 06, 2025

10 Best Micro Cap Stocks to Buy Now - Insider Monkey

Mar 06, 2025
pulisher
Mar 06, 2025

Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Cyclo Therapeutics secures $2.5 million in funding - Investing.com India

Mar 06, 2025
pulisher
Feb 28, 2025

Emerging Market ETFs: A Shield Against Trump’s Tariff Threats? - The Globe and Mail

Feb 28, 2025
pulisher
Feb 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders - The Malaysian Reserve

Feb 21, 2025
pulisher
Feb 20, 2025

CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc.CYTH - Business Wire

Feb 20, 2025
pulisher
Feb 20, 2025

Emera Inc (EMA:CA) Stock Analysis: Q4 2024 Earnings & Forecast - The Globe and Mail

Feb 20, 2025
pulisher
Feb 15, 2025

Cyclo Therapeutics extends merger agreement with Rafael Holdings - MSN

Feb 15, 2025

Cyclo Therapeutics Inc Stock (CYTH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$31.78
price up icon 3.92%
$9.75
price up icon 2.96%
$108.74
price up icon 2.66%
$8.65
price up icon 2.13%
$109.68
price up icon 2.90%
$294.60
price up icon 0.26%
Cap:     |  Volume (24h):